Rare Diseases Activities
Analyzing Hereditary Angioedema: A Review of Evidence and Treatment Approaches
0290-0000-19-102-H01-P
This webinar will explain the efficacy of current and emerging treatment for prophylaxis of acute hereditary angioedema (HAE)
1.50
Impact of von Willebrand Disease on Costs and Patient Outcomes - Featuring a Patient Perspective
0290-0000-19-093-H01-P
This activity will differentiate between current von Willebrand factors and delve into managed care and specialty pharmacy approaches to manage both the disease and its costs.
1.50
The Specialty Pharmacist's Role in Chronic Thromboembolic Pulmonary Hypertension Management
0290-0000-19-076-H01-P
This activity is designed to familiarize the audience with chronic thromboembolic pulmonary hypertension (CTEPH), a disease state with emerging pharmacotherapeutic options.
2.00
Improving the Performance of Specialty Pharmacists in the Care of Patients with Pulmonary Arterial Hypertension
0290-0000-19-019-H01-P
This activity will provide a disease state overview, summarize PAH treatments and recommendations for management, and incorporate updates from the recently published consensus documents from the 6th World
2.50